发明名称 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT
摘要 Leptin, leptin analogs, and leptin derivatives are used to treat patients wi th lipodystrophy. Leptin is effective against lipodystrophy conditions for both genetic and acquired forms of the disease. A therapeutically effective amoun t of leptin can be administered in a variety of ways, including in a vector comprising nucleic acid sequences encoding leptin. Methods of the present invention contemplate administration of leptin, leptin analogs, and leptin derivatives to patients having approximately 4 ng/ml or less before treatmen t.
申请公布号 CA2464277(A1) 申请公布日期 2003.05.01
申请号 CA20022464277 申请日期 2002.10.22
申请人 AMGEN, INC. 发明人 DEPAOLI, ALEX M.;ORAL, ELIF ARIOGLU;GARG, ABHIMANYU;TAYLOR, SIMEON I.
分类号 G01N33/53;A61K38/22;A61K38/55;A61K45/00;A61P3/04;A61P3/10;A61P43/00;G01N33/74;(IPC1-7):G01N33/53;A61K38/16;A61K38/19 主分类号 G01N33/53
代理机构 代理人
主权项
地址